Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

erenumab

A human immunoglobulin G2 (IgG2) monoclonal antibody targeting calcitonin gene-related peptide receptor (CGRPR), that can be used in the preventive treatment of migraine. Upon subcutaneous administration, erenumab specifically targets, binds to and blocks the activity of CGRPR. This may relief CGRPR-triggered migraine.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
US brand name:Aimovig
Code name:AMG 334
AMG-334
AMG334
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search